Syneos Health Increases Data Analytics Capabilities with RxDataScience Acquisition

Syneos Health, the only fully integrated biopharmaceutical solutions organization, recently announced the acquisition of RxDataScience, a leading healthcare-focused data analytics, data management and artificial intelligence (AI) company.

Together, Syneos Health and RxDataScience will offer biopharma customers technology-enabled, insights-powered solutions with the aim of accelerating performance across the product lifecycle – from lab to life.

RxDataScience’s scalable platform enables biopharma companies to transform vast volumes of data into strategic, actionable insights. Multidisciplinary teams of product managers, data scientists, engineers, developers and domain experts leveraging insights drawn from providers, payers and patients contribute to RxDataScience’s innovative software solutions, helping to deliver radical improvements that can enhance patients’ lives.  

RxDataScience further scales Syneos Health’s data science abilities, adding new capabilities and deep knowledge in data engineering and management, and advanced enterprise analytics that accelerate the time to commercialization for products and customer performance, with the potential to significantly shorten clinical trials and modernize medical affairs and commercial programs.  

RxDataScience is complementary to Kinetic™, Syneos Health’s modern customer engagement capability built to address business-critical challenges with greater precision, efficiency and effectiveness by combining behavioral science, analytics and the latest technologies to deliver fully integrated omnichannel solutions.

Kinetic looks to optimize HCP engagement through a combination of face-to-face and virtual field team activities. Syneos Health is seeing increased adoption of the digital amplifier component of Kinetic by its clinical customers, where this capability is designed to accelerate patient engagement and enrollment by driving patient referrals by physicians into clinical trials.

Syneos Health also recently acquired StudyKit, a leading technology-enabled clinical trial recruitment and retention company. Accelerating product development by better connecting patients, sites and communities, the acquisition boosts Syneos Health’s ability to deliver technology-enabled, insight-powered solutions.

Takeaway: Syneos Health continues to increase its ability to deliver strategic insights and technology-enabled solutions that address its customers’ complex data challenges